Calidi Biotherapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.86

+0.02 (+2.36%)

As of Feb 8, 2:31 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +5,507.9% upside

Low Target $29.39

Average Target $48.34

High Target $58.89

Current Price $0.86

Current
$0.86

Target
$48.34

$29.39 $48.34 avg $58.89

Scenario Analysis

Bear Case

$29.39

3,309.5%

Low target

Base Case

$48.34

+5,507.9%

Avg target

Bull Case

$58.89

+6,731.8%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$40.09

-97.8% from high

52-Week Low

$20.37

+-95.8% from low

Target vs 52W High

$48.34

+20.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%